AES - DRS - Synexus Clinical Research US, Inc. - Atlanta — Atlanta, Georgia

AES - DRS - Synexus Clinical Research US, Inc. - Atlanta is a clinical research site located in Atlanta, Georgia, United States 30328-4018.

Crixeo Clinical Trials Trust Score: 11/100 (FAILING). This profile has not yet been claimed by the site owner.

AES - DRS - Synexus Clinical Research US, Inc. - Atlanta has participated in 2 clinical trials with 1 currently active.

Therapeutic areas: SARS-CoV-2, Influenza, Chronic Obstructive Pulmonary Disease (COPD).

Sponsors: ModernaTX, Inc., Hoffmann-La Roche.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Atlanta

Browse all research sites in Georgia · View every site in Atlanta

Sponsor Feasibility Report

Trust Score: 11/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for AES - DRS - Synexus Clinical Research US, Inc. - Atlanta?

AES - DRS - Synexus Clinical Research US, Inc. - Atlanta has a Crixeo Trust Score of 11/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has AES - DRS - Synexus Clinical Research US, Inc. - Atlanta conducted?

AES - DRS - Synexus Clinical Research US, Inc. - Atlanta has 2 clinical trials on record, with 1 currently active. Their work covers SARS-CoV-2, Influenza, Chronic Obstructive Pulmonary Disease (COPD).

Is AES - DRS - Synexus Clinical Research US, Inc. - Atlanta accredited by Crixeo Clinical Trials?

AES - DRS - Synexus Clinical Research US, Inc. - Atlanta has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about AES - DRS - Synexus Clinical Research US, Inc. - Atlanta?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.